Home › Funds › Stephens Investment Management Group LLC › TVTX
Stephens Investment Management Group LLC position in TVTX
TRAVERE THERAPEUTICS INC · Health Care
Stephens Investment Management Group LLC reported holding 1,876,683 shares of TVTX (TRAVERE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$110.5M, representing 1.19% of its reported portfolio and ranking #17 among its reported holdings. Stephens Investment Management Group LLC has disclosed TVTX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Stephens Investment Management Group LLC's TVTX position evolved
Stephens Investment Management Group LLC first disclosed a stake in TVTX in Q3 2025 at 1,599,668 shares (US$38.2M). The position peaked in Q3 2026 at 1,876,683 shares, worth US$110.5M. Across 5 filings, Stephens Investment Management Group LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,876,683 shares valued at US$110.5M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 1.60M | $38.23M | New |
| Q4 2025 | 1.72M | $65.78M | Add |
| Q1 2026 | 1.80M | $53.43M | Add |
| Q2 2026 | 1.88M | $106.54M | Add |
| Q3 2026 | 1.88M | $110.50M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TVTX and 13F data
TVTX (TRAVERE THERAPEUTICS INC) is a Health Care company. 55 other funds we track also report a position in TVTX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$213.2M), Rock Springs Capital Management LP (US$123.8M), Kynam Capital Management, LP (US$113.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TVTX
- PERCEPTIVE ADVISORS LLC 3.75M sh · $213.18M · Q2 2026
- Rock Springs Capital Management LP 2.18M sh · $123.79M · Q2 2026
- Kynam Capital Management, LP 2.00M sh · $113.62M · Q2 2026
- EMERALD ADVISERS, LLC 1.56M sh · $92.06M · Q3 2026
- Context Capital Management, LLC 62.70M sh · $73.14M · Q3 2026
- MPM BioImpact LLC 1.12M sh · $63.78M · Q2 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 984.85K sh · $57.99M · Q3 2026
- Jones Hill Capital LP 959.63K sh · $56.50M · Q3 2026
- Eversept Partners, LP 798.97K sh · $45.39M · Q2 2026
- Polar Asset Management Partners Inc. 30.50M sh · $35.91M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 28.00M sh · $32.96M · Q2 2026
- ARMISTICE CAPITAL, LLC 500.00K sh · $28.41M · Q2 2026
More on Stephens Investment Management Group LLC
FAQ
How long has Stephens Investment Management Group LLC held TVTX?
Stephens Investment Management Group LLC has disclosed TVTX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is Stephens Investment Management Group LLC's current position in TVTX?
As of Q3 2026, Stephens Investment Management Group LLC holds 1.88M shares of TVTX (TRAVERE THERAPEUTICS INC), valued at $110.50M, representing 1.19% of its reported portfolio and ranking #17.
Has Stephens Investment Management Group LLC been buying or selling TVTX?
In the latest 13F filing (Q3 2026), Stephens Investment Management Group LLC held unchanged its position in TVTX. The position peaked in Q3 2026 at 1.88M shares.
Which other funds hold TVTX?
Other major institutional holders of TVTX include PERCEPTIVE ADVISORS LLC, Rock Springs Capital Management LP, Kynam Capital Management, LP, among 55 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.